Translational Research at the Aging/Cancer Interface (TRACI) (R01) | Apply Online

Opportunity Summary:

The Translational Research at the Aging/Cancer Interface (TRACI) (R01) funding opportunity (PA 12-136) was a National Institutes of Health (NIH) discretionary grant program designed to push forward translational research at the intersection of human aging and cancer. The core idea was to encourage projects that do not sit purely in basic science or purely in clinical research, but instead deliberately connect the two. Applicants were expected to use "bench-to-bedside" approaches (moving mechanistic discoveries into clinical relevance) and "bedside-to-bench" approaches (using clinical observations and patient-derived findings to drive new mechanistic or preclinical studies). The overall purpose was practical and patient-centered: generate knowledge that improves the health and well-being of older adults who are at risk for cancer or living with cancer, while also reducing functional impairment and the broader morbidity that cancer and its treatment can cause in elderly populations.

This opportunity sat across multiple NIH cancer and aging-related activity areas, reflecting how broad the scientific scope could be as long as it meaningfully addressed the overlap between aging biology and oncology with translational intent. The listed CFDA numbers indicate that the FOA could support research spanning cancer causes and prevention (93.393), detection and diagnosis (93.394), treatment (93.395), biology (93.396), control (93.399), as well as aging research (93.866). In plain terms, projects could range from studying how age-related biological changes influence tumor development, progression, and treatment response, to developing or validating diagnostic tools, interventions, or care strategies tailored to older patients. What tied these possibilities together was the expectation that findings would be relevant to real-world clinical challenges in geriatric oncology, such as vulnerability to treatment toxicity, recovery trajectories, comorbidity burden, and the preservation of function and independence.

The mechanism was the NIH R01, meaning it was intended for substantial, hypothesis-driven research projects with enough scope to support multi-year, well-developed programs of investigation. The FOA explicitly emphasized translational relevance to the care of older cancer patients, so competitive applications would typically be those that connect underlying mechanisms of aging (for example, physiological reserve, immune aging, senescence-related processes, chronic inflammation, or age-associated changes in tissue microenvironments) to clinically meaningful outcomes in cancer (such as treatment tolerance, complications, survival, symptom burden, and functional decline). Although the summary does not list specific priority topics, the framing signals strong interest in studies that can inform clinical decision-making for older adults, identify actionable targets, improve supportive care, or guide individualized treatment approaches based on aging-related risk factors.

In terms of who could apply, eligibility was intentionally broad. Domestic applicants could include state, county, city/township, and special district governments; public and state-controlled institutions of higher education; private institutions of higher education; independent school districts; public housing authorities/Indian housing authorities; and nonprofit organizations both with and without 501(c)(3) status (as long as they were not institutions of higher education when specified). For-profit organizations (other than small businesses) and small businesses were also eligible, alongside Native American tribal governments and tribal organizations. The FOA also explicitly extended eligibility to a wide range of mission-driven and historically underrepresented institution types, including Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, and U.S. territories or possessions. Notably, foreign participation was allowed: non-U.S. entities (foreign institutions) could apply, non-U.S. components of U.S. organizations were eligible, and foreign components (as defined by NIH policy) were permitted, reflecting NIH's willingness to support high-value research collaborations when scientifically justified. There was no cost-sharing or matching requirement, which is typical for many NIH research grants and reduces financial barriers for applicants.

Administratively, the FOA was posted and created on March 21, 2012, with an original and current closing date of May 7, 2015, and an archive date of June 7, 2015, meaning it is no longer active but remains part of the historical NIH funding record. The sponsoring agency was NIH, and the announcement directed applicants to the NIH grants webpage for full details. For technical issues accessing the announcement or links, the contact listed was the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.

Overall, TRACI (R01) was aimed at improving outcomes for older adults facing cancer by funding translational work that bridges fundamental aging and cancer biology with clinical realities in geriatric oncology. The intended payoff was not just better scientific understanding, but measurable improvements in prevention, diagnosis, treatment, and survivorship for an aging population, with particular attention to maintaining function and reducing the downstream burden of cancer-related morbidity in later life.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: BJA FY 12 Second Chance Act Adult Offender Comprehensive Statewide Recidivism Reduction Demonstration Program

Previous opportunity: HIV Early Intervention Services (EIS) Program Limited Competitive Service Areas (San Francisco, CA and Columbia, SC)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 12 136

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 12 136) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 12 136", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.